Contemporary management of atrial fibrillation in patients with cancer—the 2025 European Heart Rhythm Association survey
The survey revealed that, despite the lack of robust evidence specific to this patient cohort, contemporary treatment of AF in patients with active cancer or a history of cancer therapy generally follows guidelines developed for the broader AF population. These findings highlight the urgent need for more dedicated data to inform clinical decision-making in cardio-oncology patients with AF.
Authors
- Geraldine Lee (ORCID: https://orcid.org/0000-0001-6385-8600)
- Giacomo Mugnai (ORCID: https://orcid.org/0000-0003-4733-9418)
- Sergio Castrejón Castrejón
- Michael G. Fradley (ORCID: https://orcid.org/0000-0001-8352-8975)
- Michał M. Farkowski (ORCID: https://orcid.org/0000-0003-1673-7712)
- Teresa López-Fernández
- Laura Perrotta (ORCID: https://orcid.org/0009-0002-9962-5256)
- Julian K R Chun
- Diego Penela
- Josè L Merino
- Avirup Guha
- Sebastian Szmit
- Alexander R Lyon
- Giuseppe Boriani
Institutions
- University of Verona (IT)
- University of Modena and Reggio Emilia (IT)
- Humanitas University (IT)
- Augusta University (US)
- University College Cork (IE)
- Hospital Universitario La Paz (ES)
- Royal Brompton Hospital (GB)
- Hospital La Paz Institute for Health Research (ES)
- Azienda Ospedaliero-Universitaria di Modena (IT)
- Hospital Universitario Quirónsalud Madrid (ES)
- Hospital Quirónsalud Barcelona (ES)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- National Institute of Oncology (HU)
- Ministry of Interior (IT)
- Ministry of Interior and Administration (PL)
- Agaplesion Bethanien Krankenhaus (DE)
- Postgraduate School of Molecular Medicine (PL)
- Institute of Cardiology (PL)
- Agaplesion Markus Hospital (DE)
- IRCCS Humanitas Research Hospital (IT)
- University of Pennsylvania (US)
Publication Details
- Journal
- EP Europace
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1093/europace/euaf325
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00